CN114113567A - Molecular diagnosis centrifugal test card - Google Patents

Molecular diagnosis centrifugal test card Download PDF

Info

Publication number
CN114113567A
CN114113567A CN202011349824.1A CN202011349824A CN114113567A CN 114113567 A CN114113567 A CN 114113567A CN 202011349824 A CN202011349824 A CN 202011349824A CN 114113567 A CN114113567 A CN 114113567A
Authority
CN
China
Prior art keywords
cavity
detection
chamber
separator
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011349824.1A
Other languages
Chinese (zh)
Inventor
孙琦琦
王腾飞
陶顺
申东轩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edan Instruments Inc
Original Assignee
Edan Instruments Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edan Instruments Inc filed Critical Edan Instruments Inc
Priority to CN202011349824.1A priority Critical patent/CN114113567A/en
Publication of CN114113567A publication Critical patent/CN114113567A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Abstract

The application provides a molecular diagnosis centrifugation test card, this molecular diagnosis centrifugation test card includes body and lid, the body is equipped with the application of sample chamber, the runner with application of sample chamber intercommunication, the detection chamber of being connected with the runner, the waste liquid chamber with the runner intercommunication, and be equipped with the reagent in detecting the intracavity, still be equipped with the separator that melts on the body, seal up the isolation reagent in order to prevent that reagent from getting into the runner constantly at the separator unmelted state, the lid is used for sealing up the application of sample chamber. By the mode, the risk of reagent crosstalk in each detection cavity can be effectively reduced, and the storage stability of the reagents in each detection cavity can be improved.

Description

Molecular diagnosis centrifugal test card
Technical Field
The invention relates to the technical field of medical detection and analysis, in particular to a molecular diagnosis centrifugal test card.
Background
Molecular diagnosis is to utilize molecular biology technology and method to study the existence, structure or expression regulation and control change of human endogenous or exogenous biological molecules and molecular systems, and provide information and decision basis for disease prevention, prediction, diagnosis, treatment and outcome. The microfluidic technology is a technology for processing or operating micro fluid by using a micro pipeline, and has the advantages of less sample consumption, high detection speed, simple and convenient operation, multifunctional integration, small size, convenience in carrying and the like, so that the microfluidic technology is particularly suitable for developing bedside diagnosis.
The POCT (Point-of-care test) system based on the microfluidic technology and the molecular diagnosis technology is used as a new product form development trend, and has the characteristics of simple user operation, low laboratory condition requirement, low pollution risk, high flux, multi-target joint inspection, short detection time, portability of instruments and the like. The POCT molecular diagnosis system can meet the requirement of rapid on-site detection, solves various pain points detected in a central laboratory, and is widely applied to the fields of clinical examination medicine, biochemistry, molecular biology and the like. In the related art, POCT molecular diagnostic systems generally include a plurality of detection chambers, and reagents can be pre-stored in the detection chambers, however, in these systems, the detection chambers are connected with each other, so that there is a risk of reagent crosstalk, and a technical problem of poor storage stability of the reagents may be caused.
Disclosure of Invention
The invention provides a molecular diagnosis centrifugal test card, which aims to solve the technical problems that in the related technology, detection cavities are mutually communicated, so that the risk of reagent crosstalk exists, and the storage stability of a reagent is possibly poor.
In order to solve the technical problems, the invention adopts a technical scheme that: providing a molecular diagnostic centrifugation test card comprising:
the body is provided with a sample adding cavity, a flow channel communicated with the sample adding cavity, a detection cavity connected with the flow channel and a waste liquid cavity communicated with the flow channel, a reagent is arranged in the detection cavity, the body is also provided with a meltable separator, and the separator seals and separates the reagent when in an unmelted state so as to prevent the reagent from entering the flow channel;
and the cover body is used for covering the sample adding cavity.
According to a specific embodiment of the present invention, the separator includes a first separator disposed in the detection chamber, and the first separator and the reagent are layered.
According to an embodiment of the present invention, the body further includes a plurality of branch channels connected to the flow channel, the detection chambers are connected to the branch channels in a one-to-one correspondence manner, the detection chambers are connected to the flow channel through the branch channels, the branch channels are provided with isolation chambers, and the isolation body further includes a second isolation body disposed in the isolation chambers.
According to an embodiment of the present invention, the body further includes a quantitative cavity connected between the flow channel and the detection cavity, and the separator further includes a third separator disposed between the quantitative cavity and the detection cavity.
According to a specific embodiment of the present invention, a first channel, a separation blocking cavity and a second channel are further disposed between the quantification cavity and the detection cavity, the bottom of the separation blocking cavity is communicated with the bottom of the quantification cavity through the first channel, the top of the separation blocking cavity is communicated with the top of the detection cavity through the second channel, and the third separator is disposed in the separation blocking cavity and/or the first channel.
According to an embodiment of the present invention, the flow channel includes a buffer area, an exhaust area, an over-flow area, and a flow splitting area, wherein the over-flow area includes a first over-flow area, a second over-flow area, a third over-flow area, and a fourth over-flow area;
the sample adding cavity is communicated with the buffer area through the first overcurrent area, the air exhaust area is communicated with the buffer area through the second overcurrent area, the buffer area is communicated with the flow splitting area through the third overcurrent area, the flow splitting area is communicated with the waste liquid cavity and is communicated with the air exhaust area through the fourth overcurrent area, and the branch channel is communicated with the flow splitting area.
According to a specific embodiment of the present invention, the cover body includes a fixing member and a water-blocking air-permeable structural member, the sample adding cavity has an open end, one end of the fixing member is connected to the water-blocking air-permeable structural member, and the other end of the fixing member is connected to the open end of the sample adding cavity.
In order to solve the technical problems, the invention adopts a technical scheme that: the method for detecting based on the molecular diagnosis centrifugal test card comprises the following steps:
the sample application cavity receives a sample;
the molecular diagnosis centrifugal test card is driven to rotate by centrifugal force so that the sample flows to the detection cavity through the flow channel;
heating and melting the separator to cause the sample to flow into the detection chamber and mix with the reagent in the detection chamber;
centrifugally rotating to displace the separator from the sample in the detection chamber and seal the inlet end of the detection chamber;
and detecting the mixed reagent.
According to a specific embodiment of the present invention, the separator flows to the inlet end of the detection chamber under the action of the centrifugal force after being heated and melted to seal the inlet end of the detection chamber.
According to a specific embodiment of the present invention, the body further comprises a quantitative cavity connected between the flow channel and the detection cavity, and the isolation body comprises a third isolation body disposed between the quantitative cavity and the detection cavity;
the molecular diagnostic centrifugal test card being driven to rotate by centrifugal force to flow the sample through the flow channel to the detection chamber comprises:
the molecular diagnosis centrifugal test card is driven by centrifugal force to rotate so that the sample flows to the quantitative cavity through the flow channel and fills the quantitative cavity;
the heating to melt the separator such that the sample flows into the detection chamber and mixes with the reagent in the detection chamber comprises:
heating and melting the third separator to cause the sample of the quantitative chamber to flow into the detection chamber.
The invention has the beneficial effects that: the application provides a molecular diagnosis centrifugation test card includes the body, the body is equipped with the application of sample chamber, the runner with application of sample chamber intercommunication, the detection chamber of being connected with the runner, waste liquid chamber with the runner intercommunication, and be equipped with the reagent in detecting the intracavity, through be equipped with the meltable separator on the body, seal up the isolation reagent constantly in order to prevent that reagent from getting into the runner at the separator unmelted state, the risk of each detection intracavity reagent crosstalk has been reduced effectively, the storage stability of each detection intracavity reagent has also been improved simultaneously.
Drawings
In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings needed to be used in the description of the embodiments will be briefly introduced below, it is obvious that the drawings in the following description are only some embodiments of the invention, and other drawings can be obtained by those skilled in the art without inventive efforts, wherein:
FIG. 1 is a schematic diagram of the overall structure of a centrifugal test card for molecular diagnostics according to an embodiment of the present invention
FIG. 2 is a schematic diagram of an exploded structure of a centrifugal test card for molecular diagnostics provided in an embodiment of the present invention;
FIG. 3 is a schematic diagram of an exploded structure of a centrifugal test card for molecular diagnostics according to another embodiment of the present invention;
FIG. 4 is a schematic view of a reagent stored in a single layer in a first separator according to an embodiment of the present invention;
FIG. 5 is a schematic diagram of a first separator for storing reagents in a multi-layer manner according to an embodiment of the present invention;
FIG. 6 is a schematic structural diagram of a molecular diagnostic centrifugal test card with a quantitative cavity according to an embodiment of the present invention;
FIG. 7 is a schematic view of a planar barrier channel arrangement provided by an embodiment of the present invention;
FIG. 8 is a schematic diagram of the planar-direction bending-like arrangement of the blocking channels according to the embodiment of the present invention;
FIG. 9 is a schematic illustration of a curved arrangement of planar directional barrier channels provided by an embodiment of the present invention;
FIG. 10 is a schematic cross-sectional view of a molecular diagnostic centrifugation test card provided with a quantitative cavity in the thickness direction according to an embodiment of the present invention;
FIG. 11 is a cross-sectional view of a quantitative cavity with an opening at one end of the test card for molecular diagnostics centrifugation according to an embodiment of the present invention;
FIG. 12 is a cross-sectional view of a quantitative cavity with openings at two ends of the card for molecular diagnostics centrifugation according to an embodiment of the present invention;
FIG. 13 is a schematic flow chart of a one-step liquid separation detection method performed by the molecular diagnostic centrifugal test card according to the embodiment of the present invention;
fig. 14 is a schematic flow chart of a two-step liquid separation detection method performed by the molecular diagnostic centrifugation test card provided in the embodiment of the invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without inventive work based on the embodiments of the present invention, are within the scope of the present invention.
It should be noted that, if directional indications (such as up, down, left, right, front, and back … …) are involved in the embodiment of the present invention, the directional indications are only used to explain the relative positional relationship between the components, the movement situation, and the like in a specific posture (as shown in the drawing), and if the specific posture is changed, the directional indications are changed accordingly.
In addition, if there is a description of "first", "second", etc. in an embodiment of the present invention, the description of "first", "second", etc. is for descriptive purposes only and is not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include at least one such feature. In addition, technical solutions between various embodiments may be combined with each other, but must be realized by a person skilled in the art, and when the technical solutions are contradictory or cannot be realized, such a combination should not be considered to exist, and is not within the protection scope of the present invention.
Referring to fig. 1-2, a molecular diagnostic centrifuge test card 1 is provided according to an embodiment of the present invention. In some embodiments, the molecular diagnostic centrifuge test card 1 may generally include a cover 100 and a body 200. The body 200 is provided with a sample addition chamber 210, a flow channel 220 communicating with the sample addition chamber 210, a detection chamber 230 connected with the flow channel 220, and a waste liquid chamber 240 communicating with the flow channel 220. The cover 100 is used for covering the sample adding cavity 210. The detection chamber 230 is also filled with a reagent 10, and the body 200 is also provided with fusible spacers (including, but not limited to, the first and second spacers 20 and 30 shown in fig. 2 and the third spacer 40 shown in fig. 8-9). The separator is switchable between a molten state and an unmelted state (typically solid). The separator may be controlled to be in an unmelted state when untested, wherein the separator may prevent the sample from entering the detection chamber 230 through the flow channel 220, and may also serve to seal the isolated reagent 10 to prevent the reagent 10 from entering the flow channel 220 backwards, i.e., to maintain the reagent 10 in the detection chamber 230. When a test is required, the separator can be controlled to be in a molten state, and at this time, the sample can enter the flow channel 220 through the sample application cavity 210 and then further enter the detection cavity 230 to react with the reagent 10 in the detection cavity 230, thereby completing the test.
Referring specifically to fig. 2, in some embodiments, the cover 100 is substantially cylindrical. Sample addition chamber 210 includes an open end 211 adjacent one side of cover 100. When the cover body 100 covers the sample adding cavity 210, the cover body 100 can abut against the inner periphery or the outer periphery of the opening end 211, so that the cover body 100 can be tightly matched with the sample adding cavity 210 on the body 200 to seal the sample adding cavity 210. The opening end 211 may protrude from the body 200, or may be flush with the body 200, or the opening end 211 may be recessed in the body 200. When the opening end 211 protrudes from the body 200, the cover 100 can abut against the outer or inner periphery of the opening end 211. When the open end 211 is flush with the body 200 or recessed with respect to the body 200, the cover 100 can abut against the inner periphery of the open end 211. In some embodiments, when the cover body 100 is mated with the inner periphery of the open end 211, the sealing surface is relatively smaller in area and the sealing effect is relatively better.
In some embodiments, with further reference to fig. 2, the cover 100 generally includes a fastener 110 and a water-blocking, breathable structure 120. The fixing member 110 is substantially a hollow cylinder, and the water-blocking and air-permeable structure 120 is connected to the fixing member 110. In some embodiments, the water-blocking and air-permeable structure 120 and the fixing member 110 may be fixedly connected to each other, for example, by integrally molding, gluing, ultrasonic welding, laser welding, etc. to the fixing member 110. Of course, in other embodiments, the water-blocking air-permeable structure 120 may be detachably connected to the fixing element 110, for example, the fixing element 110 may be made of a material such as rubber, and the water-blocking air-permeable structure 120 may be inserted into or abutted against the fixing element 110. The fixing member 110 may be integrally formed with the water-blocking and air-permeable structure member 120 or may be formed separately, which is not specifically limited in the embodiments of the present application.
In some embodiments, the water-blocking breathable structure 120 may be connected to the inner peripheral wall or end of the fixture 110. For example, in some embodiments, the water-blocking and air-permeable structure 120 may be a film structure and may be attached to the ends of the fixture 110 by a fitting manner. Of course, in other embodiments, the water-blocking and air-permeable structure 120 may be connected to the inner wall of the fixing member 110 by means of, for example, screw connection, adhesive bonding, interference fit, etc.
In some embodiments, the water-blocking air-permeable structure 120 has at least one hole, and each hole has a pore size of less than 100 μm. The vapor generated in heating the molecular diagnosis centrifugal test card 1 can be discharged through the hole, and the air pressure in the molecular diagnosis centrifugal test card 1 can be reduced. In some embodiments, the pore size of each pore may be about 0.1-100 μm. In some embodiments, the number of the holes may be multiple, that is, the water-blocking air-permeable structure 120 may be a porous structure. In some embodiments, the water-blocking and air-permeable structure 120 may be a PE (polyethylene) sintered filter element or a PTFE (polytetrafluoroethylene) hydrophobic and air-permeable membrane. The fixing member 110 may be made of ABS (Acrylonitrile Butadiene Styrene), PP (Polypropylene), PDMS (Polydimethylsiloxane), PE (Polyethylene), or rubber. Of course, in other embodiments, the fixing member 110 and the water-blocking and air-permeable structure 120 may be implemented by other materials or other structures. The material of the fixing member 110 and the water-blocking air-permeable structure member 120 is not particularly limited.
In some embodiments, as shown in fig. 2, the water-blocking air-permeable structure 120 may be a porous sintered filter element such as described above, the number of water-blocking air-permeable structures 120 is one, and the fixture 110 is a single-layer cover structure. The fixing member 110 may generally include a first connecting cylinder 111 and a first mounting plate 112 connected to the first connecting cylinder 111. The first connecting cylinder 111 can be connected with the inner periphery or the outer periphery of the open end 211 of the sample application cavity 210 in an interference fit, spiral, snap or elastic tight fit manner. The water-blocking air-permeable structure 120 is disposed on the first mounting plate 112. The first connecting cylinder 111 may be integrally formed with the first mounting plate 112 or may be formed separately.
In some embodiments, with further reference to fig. 2, the first connecting cylinder 111 includes a first end 1111 and a second end 1112 disposed opposite the first end 1111. First end 1111 is connected to open end 211 of sample addition chamber 210, and second end 1112 is disposed distal to open end 211. The first assembly plate 112 is coupled to the second end 1112 of the first connecting cylinder 111. The first mounting plate 112 is provided with a first mounting hole 1121, and the water-blocking and air-permeable structural member 120 can be mounted in the first mounting hole 1121.
In other embodiments, the water-blocking air-permeable structure 120 may also be a hydrophobic air-permeable membrane structure, and the water-blocking air-permeable structure 120 may be attached to and seal the first mounting hole 1121. Wherein the hydrophobic breathable film structure may comprise one or more layers of hydrophobic breathable film.
The above is given to the structure in which the fixing member 110 includes the first connecting cylinder 111 and the first fitting plate 112. However, in other embodiments, the fixing member 110 may not include the first mounting plate 112, but only include the first connecting cylinder 111 with two open ends. At this time, the water-blocking and air-permeable structure 120 may also be a hydrophobic and air-permeable membrane structure, and may be connected to the end of the fixing member 110 by means of fitting. Of course, in other embodiments, the water-blocking and air-permeable structure 120 is a porous sintered filter element as described above and is attached to the inner wall of the fixture 110 by, for example, screwing, gluing, interference fit, etc. The specific structure or implementation of the components included in the fixing member 110 and the water-blocking and air-permeable structure 120 are not limited in this application.
In another embodiment, as shown in fig. 3, the water-blocking air-permeable structure 120 may be a porous sintered filter element such as described above, the number of the water-blocking air-permeable structures 120 is two, and the fixing member 110 is a double-cover structure. The fixing member 110 may generally include a first connecting cylinder 111, a first mounting plate 112, a second connecting cylinder 113, and a second mounting plate 114. Specifically, the first connecting cylinder 111 has a first end 1111 and a second end 1112 disposed opposite to the first end 1111. First end 1111 is connected to open end 211 of sample addition chamber 210, and second end 1112 is disposed distal to open end 211. The first mounting plate 112 is connected to the first connecting cylinder 111, a first mounting hole 1121 is formed in the first mounting plate 112, and one of the water-blocking and air-permeable structural members 120 is mounted in the first mounting hole 1121.
The second connector barrel 113 is connected to the second end 1112 of the first connector barrel 111. The second fitting plate 114 is attached to an end of the second connecting cylinder 113 remote from the first connecting cylinder 111. The second mounting plate 114 is provided with a second mounting hole 1141, the other water-blocking and air-permeable structure 120 is mounted on the second mounting hole 1141, and a cavity is formed between the first mounting plate 112 and the second mounting plate 114.
During the heating of the molecular diagnostic centrifuge test card 1, the generated water vapor will be discharged from the water-blocking and air-permeable structure 120, and the water vapor will form water drops when it is cooled and condense around the cover 100. When the molecular diagnostic centrifugal test card 1 is centrifugally rotated, water droplets may be thrown into the test instrument, resulting in damage to the test instrument. The cavity formed between the first assembling plate 112 and the second assembling plate 114 can collect condensed water formed by partial water vapor, and the condensed water formed on the periphery of the cover body 100 is reduced, thereby playing a role of protecting the detection instrument.
In some embodiments, the distance between the surface of the first assembly plate 112 away from the open end 211 of the sample addition cavity 210 and the second assembly plate may be greater than the distance between the surface of the second end 1112 of the first connecting cylinder 111 and the second assembly plate 114, and the first assembly plate 112 may be connected to the inner circumference of the first connecting cylinder 111, so that the cavity formed between the first assembly plate 112 and the second assembly plate 114 is further increased. In some embodiments, the first end 1111 of the first connecting cylinder 111 can be connected to the inner or outer circumference of the open end 211 of the sample application cavity 210 by interference fit, screwing, snapping, or elastic interference fit. The second connector barrel 112 may be connected to the inner or outer periphery of the second end 1112 of the first connector barrel 111 by interference fit, screwing, snapping, or elastic interference fit. Wherein the sealing surface has a relatively smaller area and a better sealing effect when coupled to the inner circumference of the open end 211 and the inner circumference of the second end 1112.
In some embodiments, the first connecting cylinder 111 and the first assembling plate 112 may be integrally formed, or may be separately formed and then connected to each other by, for example, adhesion, welding, or the like. Similarly, the second connecting tube 113 and the second mounting plate 114 may be integrally formed with each other, or may be separately formed and then connected to each other by, for example, adhesion, welding, or the like. This is not a particular limitation of the present application.
Of course, in other embodiments, the water-blocking air-permeable structure 120 may also be a hydrophobic air-permeable membrane structure, and the number of the water-blocking air-permeable structure 120 is two. Wherein each hydrophobic breathable film structure may comprise one or more layers of hydrophobic breathable film. One of the water-blocking air-permeable structures 120 may be attached to seal the first mounting hole 1121 of the first mounting plate 112, and the other water-blocking air-permeable structure 120 may be attached to the second connecting cylinder 113 at an end away from the first connecting cylinder 111 and cover the second mounting hole 1141 of the second mounting plate 114, so that a cavity may be formed between the two water-blocking air-permeable structures 120.
The above is given to the structure in which the fixing member 110 includes the first connecting cylinder 111, the first assembly plate 112, the first connecting cylinder 113, and the second assembly plate 114. However, in other embodiments, the fixing member 110 may not include the first assembly plate 112 and/or the second assembly plate 114, for example, only include the first connecting cylinder 111 with two open ends and the second connecting cylinder 113 with two open ends, or one of the first connecting cylinder 111 and the second connecting cylinder 113 may have two open ends and the other may have an assembly plate (e.g., the first assembly plate 112 or the second assembly plate 114) correspondingly disposed thereon. At this time, the water-blocking and air-permeable structure 120 may also be a hydrophobic and air-permeable membrane structure, and may be connected to the first connecting cylinder 111 and/or the second connecting cylinder 113 by means of fitting. Of course, in other embodiments, the water-blocking and air-permeable structure 120 is a porous sintered filter element as described above and is attached to the inner wall of the first connector barrel 111 and/or the second connector barrel 113 by, for example, screwing, bonding, etc. The specific structure or implementation of the components included in the fixing member 110 and the water-blocking and air-permeable structure 120 are not limited in this application.
In some embodiments of the present application, the sample application cavity 210 is sealed by the cover body 100 provided with the water-blocking air-permeable structural member 120, so that the molecular diagnosis centrifugal test card 1 can discharge water vapor generated in a heating process, and reduce air pressure in the molecular diagnosis centrifugal test card 1, thereby ensuring a good air-permeable effect, and can prevent pollutants such as aerosol, biomolecules and the like generated in an amplification reaction from escaping, and avoid pollution of detection to personnel and environment.
Referring to fig. 2-3, in some embodiments of the present application, the body 200 is substantially a fan-shaped structure, which may be a fan ring, a fan blade, or a pie. The included angle of the straight line edge of the fan-shaped structure of the body 200 can be 40-60 degrees, the inner side and the outer side are both arc edges (also can be straight line edges), the diameter of the inner arc edge can be 10-100 mm, and the diameter of the outer arc edge can be 100-200 mm. The molecular diagnosis centrifugal test card 1 adopting the size structure can be arranged at least 6 in the plane of the detector to form a circular surface, so that the molecular diagnosis centrifugal test card 1 with at least 6 can be simultaneously detected, the overall detection efficiency is improved, and the detection requirement on a larger scale can be met.
In some embodiments, with further reference to fig. 2-3, body 200 includes a base 201 and a capping layer 202. Wherein, the sample adding cavity 210, the flow channel 220, the detection cavity 230 and the waste liquid cavity 240 are arranged on the substrate 201. The capping layer 202 is attached to the surface of the base 201 and covers the flow channel 220, the detection chamber 230, and the waste chamber 240. In some embodiments, the detection chamber 230 and the waste chamber 240 may not penetrate the substrate 201, and the capping layer 202 is one layer and covers one side of the opening of the substrate 201. In other embodiments, the detection chamber 230 and the waste chamber 240 may also penetrate through the substrate 201, and in this case, the number of the capping layers 202 is two, and the capping layers are capped on two opposite sides of the substrate 201.
The substrate 201 may be made of ABS (Acrylonitrile Butadiene Styrene), PDMS (Polydimethylsiloxane), PC (Polycarbonate), PMMA (Polymethyl methacrylate), PS (General purpose polystyrene), PP (Polypropylene), COC (copolymers of Cyclo Olefin), COP (Cyclo Olefin Polymer), etc. and may be processed by injection molding, numerical control machine processing, or 3D printing. The capping layer 202 may be made of a material such as a sealing adhesive, an ultraviolet light curing adhesive, or an optical double-sided adhesive, or may be made of a material similar to that of the base 201. The seal between the capping layer 202 and the substrate 201 may be performed by, for example, ultrasonic welding, laser welding, adhesive sealing, or the like.
In addition, the bottom of the body 200 may be provided with a plurality of different protrusions or grooves 203, such as at three vertices of a fan-shaped structure. These protrusions or recesses 203 may be used to engage with retaining structures on the tray or the test instrument to position and secure.
The shapes of the areas of the sample adding cavity 210, the detection cavity 230 and the waste liquid cavity 240 can be circular arc, circle, rectangle or other polygons. The sample application chamber 210 is mainly used for pretreatment of the liquid sample, and the pretreatment may include one or more of chemical treatment, thermal treatment, enzymatic treatment, physical separation, and the like. In some embodiments, the loading chamber 210 has a volume of approximately 200-. The sample loading cavity 210 can be pre-loaded with a dry reagent, can be air-dried/dried in situ, or can be added into the sample loading cavity 210 as a freeze-dried reagent. The sample adding cavity 210 is matched with the cover body 100 to realize the sealing of the molecular diagnosis centrifugal test card 1.
The flow passage 220 may generally include a buffer region 221, an exhaust region 222, an over-flow region 223, and a flow-splitting region 224. The buffer area 221 and the exhaust area 222 may have a circular arc shape, a circular shape, a rectangular shape, or other polygonal shapes. The shape of the over-flow region 223 may be a rectangle, a circular ring, a circular arc, an arch structure, or a bent structure. The diverter region 224 may be in the shape of a circular arc, a rectangle, or other polygonal configuration. In some embodiments, the number of exhaust areas 222 may be one or more. When the number of the exhaust areas 222 is plural, the plural exhaust areas 222 may be directly communicated with the buffer area 221, or the plural exhaust areas 222 may be communicated with each other, and then the exhaust area 222 adjacent to the buffer area 221 is communicated with the buffer area 221. The number of exhaust areas 222 is not particularly limited herein.
Wherein, the buffer area 221 is communicated with the sample adding cavity 210, and can be used for temporarily storing the sample liquid in the centrifugal process.
The air-vent region 222 can be used to vent the waste air generated during the process, for example, the air can be vented into the air-vent region 222 when the sample flows from the sample-loading chamber 210 into the buffer region 221, or the water vapor generated during the heating process of the molecular diagnostic centrifuge test card 1 can be vented into the air-vent region 222.
The over-flow zones may generally include a first over-flow zone 2231, a second over-flow zone 2232, a third over-flow zone 2233, and a fourth over-flow zone 2234. Wherein the sample application chamber 210 communicates with the buffer region 221 through the first flow-through region 2231, the gas discharge region 222 communicates with the buffer region 221 through the second flow-through region 2232, the buffer region 221 communicates with the flow-splitting region 224 through the third flow-through region 2233, and the flow-splitting region 224 communicates with the waste liquid chamber 240 and communicates with the gas discharge region 222 through the fourth flow-through region 2234. Detection chamber 230 is connected to diverter region 224.
Here, there may be one or more second overcurrent areas 2232, and the opening of the second overcurrent area 2232 may be at any position on the inner wall of the buffer area 221. The second over-flow region 2232 is for a siphon action or a capillary micro-valve action. And the third and fourth flow-through regions 2233 and 2234 can be capillary valves, trap valves, siphon valves, and the like.
In some embodiments, referring further to fig. 3, the width dimension of the buffer region 221 may be greater than the width dimension of the third over-current region 2233.
Referring to FIG. 3, the detection chamber 230 may be a substantially conical, cylindrical-conical composite or rectangular structure, and may have a volume of 10-100 μ l. Wherein, the depth of the detection cavity 230 is greater than the depth of the flow channel 220. In some embodiments, a bypass 250 may also be provided between detection chamber 230 and flow channel 220 (and specifically diverter region 224). In some embodiments, the number of the detection cavities 230 may be multiple, and the number of the branches 250 is also multiple, and the detection cavities 230 correspond to the branches 250 one by one. Each detection chamber 230 may be connected to diverter region 224 by a branch 250. In addition, the detection cavities 230 are isolated from each other, so that the probability of reaction cross contamination among different detection cavities 230 can be reduced, and the same sample can be used for differential diagnosis of multiple pathogens at the same time by placing different reaction reagents in different detection cavities 230. In the embodiment shown in fig. 3, the number of detection chambers 230 is 5, and the number of branches 250 is also 5. .
Referring also to fig. 4-5, in some embodiments, the reagent 10 and the meltable first separator 20 are stacked within the detection chamber 230. In some embodiments, the first insulation 20 may be paraffin, microcrystalline wax, synthetic wax, or natural wax. The first separator 20 is characterized in that it is solid at normal and low temperatures, turns into liquid after being heated to a specific temperature, and has no inhibitory effect on nucleic acid amplification reaction. In some embodiments, the reagent 10 is a dry reagent comprising one or more of primers and DNA (deoxyribonucleic acid) binding dyes, enzymes, magnesium sulfate, potassium chloride, dNTPs (nucleotide triphosphates) used for the amplification reaction. The dry reagent 10 is loaded in the detection chamber 230 in a liquid state, and the dry reagent 10 is formed through a drying process, the temperature of which is lower than the melting temperature of the first separator 20, the drying process including air drying, oven drying, and freeze drying. In the heating process of detection, the reagent 10 and the first insulator 20 are both in liquid state, and since the specific gravity of the first insulator 20 is smaller than that of the reagent 10, the first insulator 20 is displaced out of the detection chamber 230 under the action of the centrifugal field, thereby not affecting the reaction and detection.
Therefore, when such a first separator 20 is used, the first separator 20 can be loaded in the detection chamber 230 in a molten state and molded by natural solidification or solidification at a reduced temperature. When not being tested, the first separator 20 may be controlled to be in a molten state, at which time the sealed and isolated storage of the reagent 10 may be achieved by the first separator 20. When a test needs to be performed, the first isolation body 20 may be controlled to be in a molten state, for example, by heating the molecular diagnostic centrifugal test card 1, so that the first isolation body 20 is heated and melted, at this time, the first isolation body 20 may move out of the detection cavity 230 and flow to the end of the branch channel 250 under the action of centrifugal force, and a sample may enter the detection cavity 230 through the branch channel 250, and then the first isolation body 20 is cured again to block the end of the branch channel 250, thereby forming mutually isolated seals for the plurality of detection cavities 230, so as to facilitate independent reaction or test between the detection cavities 230.
As shown in FIG. 4, in some embodiments, the number of layers of the reagent 10 may be one, with the reagent 10 being located at the bottom of the detection chamber 230. And the first separator 20 may comprise a facing separator 21. The facing layer separator 21 covers the reagent 10 and is in sealing engagement with the inner peripheral wall of the detection chamber 230. In this way, the reagent 10 can be isolated from the outside by the first isolation body 20 when not being tested, thereby effectively increasing the storage time of the reagent 10 and reducing the possibility of contamination of the reagent 10. In the heating process of detection, the reagent 10 and the first insulator 20 are both in liquid state, and since the specific gravity of the first insulator 20 is smaller than that of the reagent 10, the first insulator 20 is displaced out of the detection chamber 230 under the action of the centrifugal field, thereby not affecting the reaction and detection.
In some embodiments, referring to fig. 5, the first separator 20 may be at least one layer of the separators 22, and the reagent 10 has a plurality of layers, the plurality of layers of the reagent 10 being spaced apart from each other, and two adjacent layers of the reagent 10 may be sealed at intervals by the layer of the separators 22.
For example, in the embodiment shown in fig. 5, two layers of reagents 10 may be included, and the types of the two layers of reagents 10 may be different, namely, a first reagent 11 and a second reagent 12. The reagent 11 and the reagent 12 may be sealed at intervals in layers by an interlayer separator 22. Of course, in other embodiments, three or more layers of reagents may be included, and these may be stacked in between, for example: by the above manner, the first reagent 11+ the interlayer isolation body 22+ the second reagent 12+ the interlayer isolation body 22 … … can realize that a plurality of reagents 10 are simultaneously stored in the detection cavity 230 in an isolated manner and protected from the outside, thereby effectively prolonging the storage time of the reagents 10 and reducing the possibility of pollution of the reagents 10. Meanwhile, in the detection heating process, the plurality of reagents 10 and the plurality of layers of first separators 20 are in a liquid state, and since the specific gravity of the first separators 20 is smaller than that of the reagents 10, the first separators 20 are displaced out of the detection chamber 230 under the action of the centrifugal field, so that the reaction and detection are not affected.
In some embodiments, with further reference to FIG. 5, the first separator 20 can further comprise a surface layer separator 21, and the surface layer separator 21 covers the top surface of the topmost reagent 10 and is in sealing engagement with the inner peripheral wall of the detection chamber 230 for further sealing separation of the reagent 10 in the detection chamber 230.
In some embodiments of the present application, the reagent 10 is protected from the outside by covering the first isolation body 20 on the upper surface of the reagent 10 at the bottom of the detection chamber 230, so that the preservation time of the reagent 10 is effectively prolonged, and the reagent 10 is prevented from being polluted. The interlayer isolation body 22 is arranged to isolate the multiple reagents 10 (reagent 11/reagent 12) in a layered manner, so that the detection cavity 230 can simultaneously store multiple dry reagents 10 in an isolated manner, and the molecular diagnosis centrifugal test card 1 has multiple functions and wider application range.
The reagent 10 and the first isolating body 20 can be pre-assembled in various ways, such as manual pipetting, machine pipetting, manual dispensing, machine dispensing, and the like. The processing sequence is firstly reagent 11, drying, interlayer isolation 22, solidifying, reagent 12 and drying. When the molecular diagnostic centrifuge test card 1 is packaged/sealed after the preassembly of the reagent 10 and the first insulating body 20 is completed, a high-temperature heat source or a long-time heating mode is avoided as much as possible, and if heating is needed, the heating temperature needs to be 5-10 ℃ lower than the melting temperature of the first insulating body 20.
In some embodiments, the branch 250 has a depth of 1mm or less and a width of 1mm or less. Branch 250 communicates with diverging region 224. Referring further to fig. 2-3, an isolation chamber 251 may also be provided in the branch 250. Herein, the isolation chamber 251 may be disposed at any position of the branch passage 250, and the number of the isolation chamber 251 may be one or more. The isolation chamber 251 may be a cylindrical recess, and the volume of the isolation chamber 251 may be 5-50 μ l. A second separator 30 may be disposed within the separation cavity 251. Wherein, the material of the second separator 30 is the material of the first separator 20 as described above, and the description thereof is omitted. The material of the second separator 30 may be the same as or different from that of the first separator 20. The second isolating body 30 is used for sealing the inlet of the detection chamber 230, so that the whole course of the reaction liquid is isolated from the outside in the amplification process, the aerosol can be effectively isolated, and the possibility of pollution of detection to personnel and environment is reduced.
Referring to fig. 6-12, in some embodiments, the molecular diagnostic centrifugation test card 1 includes a cover 100 and a body 200. The body 200 is provided with a sample addition chamber 210, a flow channel 220 communicating with the sample addition chamber 210, a detection chamber 230 connected with the flow channel 220, and a waste liquid chamber 240 communicating with the flow channel 220. The structural arrangement and connection relationship among the cover 100, the sample-adding cavity 210, the flow channel 220, and the detection cavity 230 can be seen in the embodiments shown in fig. 2-5, and are not described herein again. Unlike the previous embodiments, in the embodiment shown in fig. 6-12, the body 200 is not provided with the branch 250, but is provided with the dosing chamber 260. The quantitative chamber 260 is in communication with the flow channel 220 (specifically, the flow splitting region 224) and the detection chamber 230, respectively. In one embodiment, the number of the detection chambers 230 may be plural, and the number of the quantitative chambers 260 may be correspondingly plural, and each quantitative chamber 260 is connected to one detection chamber 230.
The quantitative cavity 260 may be a groove structure, has a predetermined volume, can be used for temporarily storing the sample liquid, and can quantify the volume of the sample liquid. In some embodiments, the predetermined volume is substantially in the range of 5 μ l to 100 μ l. The cross-sectional shape of the quantitative cavity 260 may be an arch, a circular arc, a triangle, a rectangle, etc., and other polygons.
Referring further to fig. 6-12, an isolation channel is provided between the dosing chamber 260 and the detection chamber 230, the third separator 40 is disposed within the isolation channel, and when the third separator 40 is melted, the isolation channel allows liquid to flow from the dosing chamber 260 to the detection chamber 230 under the influence of centrifugal force and prevents liquid in the detection chamber 230 from flowing back to the dosing chamber 260.
In some embodiments, the isolation channel is disposed in the card-plane direction of the molecular diagnostic centrifugation test card 1. As shown in FIGS. 7 to 9, the isolation channel may have a straight shape (as shown in FIG. 7), a bent straight shape (as shown in FIG. 8), or a curved shape (as shown in FIG. 9), and includes a first channel 261 adjacent to the dosing chamber 260, a second channel 263 adjacent to the detection chamber 230, and a blocking chamber 262 between the first channel 261 and the second channel 263 for installing the third separator 40. By using the isolation channel with a straight bending shape or a curved shape, the liquid in the detection chamber 230 can be better prevented from flowing back to the quantitative chamber 260.
In some embodiments, the isolation channel is disposed in a card thickness direction of the molecular diagnostic centrifugation test card 1. As shown in FIGS. 10 to 12, the isolation path includes a first path 261 adjacent to the quantifying chamber 260, a second path 262 adjacent to the detecting chamber 230, and an isolation chamber 262 between the first path 261 and the second path 263 for accommodating the third isolating body 40, and the first path 261, the isolation chamber 262, and the second path 263 may constitute a stepped path.
The material of the third separator 40 is the material of the first separator 20 as described above, and will not be described in detail here. For example, the third separator 40 may be one of paraffin, microcrystalline wax, synthetic wax, or natural wax.
In this embodiment, when the centrifugal test card 1 for molecular diagnostics is rotated centrifugally, the sample liquid flows to the quantification chamber 270 through the sample application chamber 210 and the flow channel 220. The third separator 40 is in a solid state, so that the blocking chamber 262 between the quantitative chamber 260 and the detection chamber 230 is sealed, the sample liquid cannot flow to the detection chamber 230, only the quantitative chamber 260 is filled, and the surplus liquid flows to the waste liquid chamber 240. After the sample liquid is heated, the third insulating body 40 is heated to melt and flow to the detection cavity 230, so that the quantitative cavity 260 and the detection cavity 230 can be communicated, and the quantitative sample liquid in the quantitative cavity 260 can flow into the detection cavity 230 through the first channel 261, the blocking cavity 262 and the second channel 263. Since the third separator 40 has a specific gravity smaller than that of the reagent 10, the third separator 40 is displaced above the reagent 10 by the centrifugal field, and the reaction and detection are not affected, and the detection chamber 230 can be sealed.
In some embodiments, body 200 includes a base 201 and a capping layer 202. The materials and processing manners of the substrate 201 and the capping layer 202 can be described with reference to the embodiments shown in fig. 2-3. Wherein, the sample adding cavity 210, the flow channel 220, the detection cavity 230, the waste liquid cavity 240 and the quantitative cavity 260 are arranged on the substrate 201. The capping layer 202 is attached to the surface of the base 201 and covers the flow channel 220, the detection chamber 230, the waste chamber 240, and the quantification chamber 260.
In some embodiments, the detection chamber 230, the blocking chamber 262 and the quantitative chamber 260 may not penetrate through the substrate 201, and the capping layer 202 is formed in one layer and covers one side of the opening of the substrate 201. For example, referring to fig. 8, in some embodiments, the substrate 201 has a top surface and a bottom surface, which are the two sides of the substrate 201 in the thickness direction. The dosing chamber 260, the blocking chamber 262 and the detection chamber 230 have an open end on one of the top and bottom surfaces and a closed end on the other of the top and bottom surfaces. In addition, the base 201 has a first connection 2011 between the dosing chamber 260 and the blocking chamber 262 and a second connection 2012 between the blocking chamber 262 and the detection chamber 230.
When the open end is located on the top surface, as shown in fig. 11, the first connecting portion 2011 and the bottom surface are spaced to form a first channel 261, the second connecting portion 2012 and the plane of the top surface are spaced to form a second channel 263, and the second channel 263 extends through to the top surface. The capping layer 202 caps the top surface of the substrate 201.
In some embodiments, when the open end is located at the bottom surface (not shown), the first connecting portion 2011 and the plane of the bottom surface are spaced to form the first channel 261, the second connecting portion 2012 and the top surface are spaced to form the second channel 263, and the first channel 261 extends through to the bottom surface. The capping layer 202 caps the bottom surface of the substrate 201.
In some embodiments, the detection chamber 230, the blocking chamber 262 and the quantitative chamber 260 may also penetrate through the substrate 201, and at this time, the number of the capping layers 202 is two and the capping layers are capped on two opposite sides of the substrate 201. For example, referring to fig. 12, the base 201 has a top surface and a bottom surface, and the dosing chamber 260, the blocking chamber 262 and the detection chamber 230 each have two open ends in a direction from the top surface toward the bottom surface. The first channel 261 is formed to be recessed from the bottom surface of the base 201 toward the top surface of the base 201, the second channel 263 is formed to be recessed from the top surface of the base 201 toward the bottom surface of the base 201, and both the recessed depth of the first channel 261 and the recessed depth of the second channel 263 are smaller than the depth of the detection chamber 230. Two capping layers 202 may cap the top and bottom surfaces of the substrate 201.
In some embodiments of the present application, the quantitative liquid distribution is realized by the quantitative cavity 260 and the third isolating body 40, so that the third isolating body 40 can realize quantitative liquid distribution through the quantitative cavity 260 before melting, and can further assist the mutually isolated storage of the reagents in the detection cavity 230. After being heated and melted, the quantitative cavity 260 can be communicated with the detection cavity 230 so that the sample can enter the detection cavity 230 for subsequent detection, and meanwhile, the third isolating body 40 can further play a role in sealing the detection cavity 230, thereby realizing the automation of quantitative detection and analysis of the sample reagent of the molecular diagnosis centrifugal test card 1.
Some embodiments of the present application also provide a method for performing detection based on the above-mentioned molecular diagnostic centrifugation test card 1. Fig. 13 shows a method of detection based on the molecular diagnostic centrifuge test card 1 in the embodiment shown in fig. 2-3. As shown in fig. 13, in some embodiments, the specific steps of the one-step liquid separation detection method are as follows:
step S10: sample application chamber 210 receives a sample.
In this step, the sample is pretreated by heating. The heating mode can be a metal heating block, a heating air flow, an electromagnetic wave (infrared radiation, laser, microwave) and the like. The heating regions of the molecular diagnosis centrifugal test card 1 are non-overlapping heating regions, so that independent heating at different time points can be realized, and in the step, only one heating region (namely, the vicinity of the sample adding cavity 210) needs to be heated. The heating zone is warmed to a specified temperature, such as 90 ℃. And after reaching the specified temperature, preserving heat for 3-10min according to the specified requirement to realize pretreatment. After the pretreatment is completed, the temperature of the sample liquid is lowered to a prescribed temperature, for example, 60 ℃.
Step S11: the molecular diagnostic centrifugation test card 1 is rotated by a centrifugal force to allow the sample to flow toward the detection chamber 230 through the flow channel 220.
In this step, the molecular diagnostic centrifuge test card 1 needs to be rotation-controlled. For example, the direction of rotation may be controlled to be clockwise, the rotation speed greater than 1000rpm, and the rotation time about 10-15 s. By rotation, the sample liquid can flow from the sample application chamber 210 to the detection chamber 230 through the buffer zone 221 of the flow channel 220, so as to subsequently fill the detection chamber 230 with the sample. And excess sample fluid will enter waste chamber 240.
Step S12: the heat melts the separator to cause the sample to flow into the detection chamber 230 and mix with the reagent 10 in the detection chamber 230.
In this step, the heating second region (i.e., the vicinity of the detection chamber 230) is heated so that the temperature of the heating second region is higher than the melting point of the first separator 20 and the second separator 30 of the isolation chamber 251, thereby melting the first separator 20 and the second separator 30 of the isolation chamber 251, and mixing the sample with the reagent in the detection chamber 230.
Step S13: the centrifuge spins to displace the separator from the sample in the detection chamber 230 and seal the inlet end of the detection chamber 230.
In this step, the molecular diagnostic centrifuge test card 1 is subjected to rotation control. Wherein, the motor can rotate along the clockwise direction, the rotating speed is more than 1000rpm, and the rotating time is 10-15 s. At this time, the sample enters the detection chamber 230 due to the rotation of the molecular diagnostic centrifuge test card 1, and the first separator 20 and the aqueous solution in the detection chamber 230 are displaced, and the first separator 20 is transferred to the inlet end of the detection chamber 230, thereby completing the sealing of each detection chamber 230. And then changing the control parameters of the motor to make the molecular diagnosis centrifugal test card 1 rotate clockwise and anticlockwise alternately. For example, the molecular diagnostic centrifuge test card 1 may be controlled to rotate clockwise at a rotation speed of 3000rpm for a rotation time of 1s, and then rotate counterclockwise at a rotation speed of 3000rpm for a rotation time of 1s, alternately rotating 10 to 15 times. The clockwise and counterclockwise rotation can make the sample and the reagent in the detection chamber 230 mix and dissolve completely. Meanwhile, the separator flows to the inlet end of the detection chamber 230 by centrifugal force after being heated and melted, to seal the inlet end of the detection chamber 230.
Step S14: and detecting the mixed reagent.
In this step, an amplification reaction and detection are required. If real-time detection is used, detection and amplification reactions are performed simultaneously, and if endpoint detection is used, detection is performed after amplification is complete. Wherein, the amplification reaction can be realized by the following modes: the heating zone two (i.e. near the detection chamber 230) is heated, and the temperature is controlled within the range of 60-75 ℃. And after the heating zone II reaches the specified temperature, preserving the heat for 30-60min according to the specified requirement to finish the amplification reaction.
Fig. 14 shows a method of detection based on the molecular diagnostic centrifuge test card 1 in the embodiment shown in fig. 6-12. As shown in fig. 14, in another embodiment of the present application, a two-step liquid separation detection method is implemented, and the detection method specifically includes the following steps:
step S20: sample application chamber 210 receives a sample.
In this step, the sample processing method of the sample addition chamber 210 is the same as that in step S10, and will not be described in detail here.
Step S21: the molecular diagnostic centrifugal test card 1 is rotated by centrifugal force to make the sample flow to the quantitative cavity 260 through the flow channel 220 and fill the quantitative cavity 260.
In this step, the molecular diagnostic centrifuge test card 1 needs to be rotated and controlled, and the rotation parameters are set to be clockwise in the rotation direction, the rotation speed is more than 1000rpm, and the rotation time is 10-15 s. The sample liquid flows from the sample application chamber 210 to the quantitative chamber 260 through the flow channel 220, and fills the quantitative chamber 20. Excess sample fluid will enter waste chamber 240.
Step S22: the third separator 40 is melted by heating so that the sample of the quantitative chamber 260 flows into the detection chamber 230.
In this step, the heating second zone is heated so that the temperature of the heating second zone is higher than the melting points of the first and third separators 20 and 40, and the first and third separators 20 and 40 in the detection chamber 230 are melted, so that the sample flows from the quantification chamber 260 into the detection chamber 230 through the first channel 261, the blocking chamber 262, and the second channel 263, and is mixed with the reagent in the detection chamber 230.
Step S23 is centrifugal rotation to displace the separator with the sample in the detection chamber 230 and seal the inlet end of the detection chamber 230.
In this step, the molecular diagnostic centrifuge test card 1 is subjected to rotation control. Wherein, the motor can rotate along the clockwise direction, the rotating speed is more than 1000rpm, and the rotating time is 10-15 s. At this time, due to the rotation of the molecular diagnostic centrifuge test card 1, the sample in the quantitative chamber 260 enters the detection chamber 230, and the first separator 20 and the aqueous solution in the detection chamber 230 are displaced, the first separator 20 and the third separator 40 can be transferred to the inlet end of the detection chamber 230, thereby completing the sealing of each detection chamber 230. And then changing the control parameters of the motor to make the molecular diagnosis centrifugal test card 1 rotate clockwise and anticlockwise alternately. For example, the molecular diagnostic centrifuge test card 1 may be controlled to rotate clockwise at a rotation speed of 3000rpm for 1s and then rotate counterclockwise at a rotation speed of 3000rpm for 1s, and to rotate alternately 10-15 times, so that the sample in the detection chamber 230 is mixed with the reagent and completely dissolved. Meanwhile, the first separator 20 and the third separator 40 flow to the inlet end of the detection chamber 230 by centrifugal force after being heated and melted, to seal the inlet end of the detection chamber 230.
Step S24: and detecting the mixed reagent.
In this step, the processing method for detecting the mixed reagent is the same as that in step S14, and will not be described in detail here.
In summary, in some embodiments of the present application, the integrated design eliminates the need for higher environmental requirements for molecular diagnostics, thereby greatly reducing the detection time; the water-blocking and air-permeable structural member 120 is arranged on the cover body 100 to cover the sample adding cavity 210, so that the molecular diagnosis centrifugal test card 1 can ensure good air permeability, reduce the air pressure in the molecular diagnosis centrifugal test card 1, has good sealing performance and can prevent pollutants such as aerosol, biological molecules and the like from escaping; the first isolating body 20 covers the upper surface of the reagent 10 at the bottom of the detection cavity 230, so that the reagent 10 is protected from the outside, the storage time of the reagent 10 is effectively prolonged, and the pollution of the reagent 10 is avoided; the detection chamber 230 can store a plurality of dry reagents 10 by the first separator 20 as a plurality of reagents 10 (reagent 11/reagent 12); through being equipped with quantitative chamber 260 and third insulator 40 for third insulator 40 plays the quantitative liquid effect of dividing before melting, plays the effect of sealed detection chamber 230 after melting, has realized the automation of the quantitative determination analysis of molecular diagnosis centrifugal test card 1 sample reagent, and isolated aerosol effectively avoids detecting the pollution to personnel and environment.
The above description is only an embodiment of the present invention, and not intended to limit the scope of the present invention, and all modifications of equivalent structures and equivalent processes, which are made by using the contents of the present specification and the accompanying drawings, or directly or indirectly applied to other related technical fields, are included in the scope of the present invention.

Claims (10)

1. A molecular diagnostic centrifugation test card, comprising:
the body is provided with a sample adding cavity, a flow channel communicated with the sample adding cavity, a detection cavity connected with the flow channel and a waste liquid cavity communicated with the flow channel, a reagent is arranged in the detection cavity, the body is also provided with a meltable separator, and the separator seals and separates the reagent when in an unmelted state so as to prevent the reagent from entering the flow channel;
and the cover body is used for covering the sample adding cavity.
2. The molecular diagnostic centrifugation test card of claim 1, wherein the separator comprises a first separator disposed within the detection chamber, the first separator being layered with the reagent.
3. The molecular diagnostic centrifugation test card of claim 1, wherein the body further comprises a plurality of branches connected to the flow channel, the plurality of detection chambers are connected to the plurality of branches in a one-to-one correspondence, the detection chambers are connected to the flow channel through the branches, the branches are provided with isolation chambers, and the isolation body further comprises a second isolation body disposed in the isolation chambers.
4. The molecular diagnostic centrifugation test card of claim 1, wherein the body further comprises a dosing chamber connected between the flow channel and the detection chamber, and the separator further comprises a third separator disposed between the dosing chamber and the detection chamber.
5. The molecular diagnostic centrifugation test card of claim 4, wherein a first channel, a separation blocking cavity and a second channel are further arranged between the quantification cavity and the detection cavity, the bottom of the separation blocking cavity is communicated with the bottom of the quantification cavity through the first channel, the top of the separation blocking cavity is communicated with the top of the detection cavity through the second channel, and the third isolating body is arranged in the separation blocking cavity and/or the first channel.
6. The molecular diagnostic centrifuge test card of claim 3 wherein the flow channel comprises a buffer region, a vent region, an over-flow region, a flow-splitting region, the over-flow region comprising a first over-flow region, a second over-flow region, a third over-flow region, a fourth over-flow region;
the sample adding cavity is communicated with the buffer area through the first overcurrent area, the air exhaust area is communicated with the buffer area through the second overcurrent area, the buffer area is communicated with the flow splitting area through the third overcurrent area, the flow splitting area is communicated with the waste liquid cavity and is communicated with the air exhaust area through the fourth overcurrent area, and the branch channel is communicated with the flow splitting area.
7. The molecular diagnostic centrifugation test card of claim 1, wherein the cover comprises a fixing member and a water-blocking air-permeable structure, the sample application cavity has an open end, one end of the fixing member is connected with the water-blocking air-permeable structure, and the other end of the fixing member is connected with the open end of the sample application cavity.
8. A method for performing detection based on the molecular diagnostic centrifugation test card of claim 1, comprising:
the sample application cavity receives a sample;
the molecular diagnosis centrifugal test card is driven to rotate by centrifugal force so that the sample flows to the detection cavity through the flow channel;
heating and melting the separator to cause the sample to flow into the detection chamber and mix with the reagent in the detection chamber;
centrifugally rotating to displace the separator from the sample in the detection chamber and seal the inlet end of the detection chamber;
and detecting the mixed reagent.
9. The method according to claim 8, wherein the separator flows to an inlet end of the detection chamber under the centrifugal force after being heated and melted to seal the inlet end of the detection chamber.
10. The method of claim 8, wherein the body further comprises a dosing chamber connected between the flow channel and the detection chamber, and the separator comprises a third separator disposed between the dosing chamber and the detection chamber;
the molecular diagnostic centrifugal test card being driven to rotate by centrifugal force to flow the sample through the flow channel to the detection chamber comprises:
the molecular diagnosis centrifugal test card is driven by centrifugal force to rotate so that the sample flows to the quantitative cavity through the flow channel and fills the quantitative cavity;
the heating to melt the separator such that the sample flows into the detection chamber and mixes with the reagent in the detection chamber comprises:
heating and melting the third separator to cause the sample of the quantitative chamber to flow into the detection chamber.
CN202011349824.1A 2020-11-26 2020-11-26 Molecular diagnosis centrifugal test card Pending CN114113567A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011349824.1A CN114113567A (en) 2020-11-26 2020-11-26 Molecular diagnosis centrifugal test card

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011349824.1A CN114113567A (en) 2020-11-26 2020-11-26 Molecular diagnosis centrifugal test card

Publications (1)

Publication Number Publication Date
CN114113567A true CN114113567A (en) 2022-03-01

Family

ID=80360729

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011349824.1A Pending CN114113567A (en) 2020-11-26 2020-11-26 Molecular diagnosis centrifugal test card

Country Status (1)

Country Link
CN (1) CN114113567A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117225487A (en) * 2023-08-31 2023-12-15 湖北微流控科技有限公司 Microfluidic chip

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100240142A1 (en) * 2007-11-08 2010-09-23 Panasonic Corporation Analyzing device and analyzing method using same
CN103464230A (en) * 2013-09-25 2013-12-25 中国科学院长春光学精密机械与物理研究所 Centrifugal whole blood analysis micro-fluidic chip, preparation method as well as application method thereof
CN104136123A (en) * 2012-01-09 2014-11-05 精密公司 Microfluidic reactor system
CN107557452A (en) * 2017-08-02 2018-01-09 南京岚煜生物科技有限公司 A kind of micro-fluidic chip for nucleic acid amplification detection
CN107643411A (en) * 2017-08-11 2018-01-30 深圳市芯思微生物科技有限公司 Micro-fluidic chip, its preparation method and application method
CN108443578A (en) * 2018-01-21 2018-08-24 南京大学 A kind of centrifugal force micro-fluidic chip
CN108642148A (en) * 2018-07-09 2018-10-12 南京岚煜生物科技有限公司 A kind of nucleic acid amplification detection micro-fluidic chip and its detection method
CN108865821A (en) * 2018-07-09 2018-11-23 杭州霆科生物科技有限公司 A kind of the nucleic acid isothermal amplification chip and application method of integrated thermal cracking
CN208748118U (en) * 2018-07-09 2019-04-16 南京岚煜生物科技有限公司 A kind of nucleic acid amplification detection micro-fluidic chip
CN110029052A (en) * 2019-04-18 2019-07-19 深圳市刚竹医疗科技有限公司 Micro-fluidic chip and analysis system
CN110339880A (en) * 2019-07-10 2019-10-18 深圳市刚竹医疗科技有限公司 Reagent sequence loading method, device and microfluidic system based on phase transformation valve
CN209901312U (en) * 2019-05-13 2020-01-07 烟台芥子生物技术有限公司 Centrifugal micro-fluidic reagent dish
CN111744564A (en) * 2020-05-26 2020-10-09 深圳市刚竹医疗科技有限公司 Controllable reagent container for centrifugal microfluidics and centrifugal microfluidics chip
CN211865062U (en) * 2019-10-21 2020-11-06 广州万孚生物技术股份有限公司 Micro-fluidic chip and in-vitro detection system
CN111965345A (en) * 2020-09-08 2020-11-20 深圳市亚辉龙生物科技股份有限公司 Microfluidic immunodetection chip and microfluidic linear immunodetection method

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100240142A1 (en) * 2007-11-08 2010-09-23 Panasonic Corporation Analyzing device and analyzing method using same
CN104136123A (en) * 2012-01-09 2014-11-05 精密公司 Microfluidic reactor system
CN103464230A (en) * 2013-09-25 2013-12-25 中国科学院长春光学精密机械与物理研究所 Centrifugal whole blood analysis micro-fluidic chip, preparation method as well as application method thereof
CN107557452A (en) * 2017-08-02 2018-01-09 南京岚煜生物科技有限公司 A kind of micro-fluidic chip for nucleic acid amplification detection
CN107643411A (en) * 2017-08-11 2018-01-30 深圳市芯思微生物科技有限公司 Micro-fluidic chip, its preparation method and application method
CN108443578A (en) * 2018-01-21 2018-08-24 南京大学 A kind of centrifugal force micro-fluidic chip
CN108642148A (en) * 2018-07-09 2018-10-12 南京岚煜生物科技有限公司 A kind of nucleic acid amplification detection micro-fluidic chip and its detection method
CN108865821A (en) * 2018-07-09 2018-11-23 杭州霆科生物科技有限公司 A kind of the nucleic acid isothermal amplification chip and application method of integrated thermal cracking
CN208748118U (en) * 2018-07-09 2019-04-16 南京岚煜生物科技有限公司 A kind of nucleic acid amplification detection micro-fluidic chip
CN110029052A (en) * 2019-04-18 2019-07-19 深圳市刚竹医疗科技有限公司 Micro-fluidic chip and analysis system
CN209901312U (en) * 2019-05-13 2020-01-07 烟台芥子生物技术有限公司 Centrifugal micro-fluidic reagent dish
CN110339880A (en) * 2019-07-10 2019-10-18 深圳市刚竹医疗科技有限公司 Reagent sequence loading method, device and microfluidic system based on phase transformation valve
CN211865062U (en) * 2019-10-21 2020-11-06 广州万孚生物技术股份有限公司 Micro-fluidic chip and in-vitro detection system
CN111744564A (en) * 2020-05-26 2020-10-09 深圳市刚竹医疗科技有限公司 Controllable reagent container for centrifugal microfluidics and centrifugal microfluidics chip
CN111965345A (en) * 2020-09-08 2020-11-20 深圳市亚辉龙生物科技股份有限公司 Microfluidic immunodetection chip and microfluidic linear immunodetection method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117225487A (en) * 2023-08-31 2023-12-15 湖北微流控科技有限公司 Microfluidic chip

Similar Documents

Publication Publication Date Title
EP2297586B1 (en) Cartridge containing reagent, microfluidic device including the cartridge, method of manufacturing the microfluidic device, and biochemical analysis method using the microfluidic device
KR100883951B1 (en) Device having a self sealing fluid port
Gorkin et al. Centrifugal microfluidics for biomedical applications
US6532997B1 (en) Sample processing device with integral electrophoresis channels
US6251343B1 (en) Microfluidic devices and systems incorporating cover layers
Hess et al. Review on pneumatic operations in centrifugal microfluidics
JP4964955B2 (en) Disposable device for liquid sample analysis by nucleic acid amplification
WO2008119470A1 (en) Device for performing multiple analyses in parallel
EP2165764B1 (en) Microfluidic device
US11268631B2 (en) Microfluidic valve and a chip or system comprising the microfluidic valve
US20080248590A1 (en) Device For Carrying Out A Biological Assay
US10416054B2 (en) Blood collector with capillary structure
US20100175993A1 (en) Disc-shaped microfluidic device capable of detecting electrolytes included in specimen by using electrochemical method
WO1998053311A9 (en) Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system
US20190070607A1 (en) Fluid handling device and method of handling fluids
US20120230887A1 (en) Devices and methods for interfacing microfluidic devices with macrofluidic devices
US20100044918A1 (en) Method of preparing solid reagent and microfluidic device employing the solid reagent
Johnson et al. Integration of multiple components in polystyrene-based microfluidic devices part I: fabrication and characterization
CN112261996A (en) Microfluidic device, method for the production thereof and use thereof
JP5046412B2 (en) Microfluidic device and system incorporating a coating layer
CN215250839U (en) Molecular diagnosis centrifugal test card
CN214654906U (en) Molecular diagnosis centrifugal test card
Attia et al. Integration of functionality into polymer-based microfluidic devices produced by high-volume micro-moulding techniques
CN114113567A (en) Molecular diagnosis centrifugal test card
CN214654798U (en) Molecular diagnosis centrifugal test card

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination